Central Pharmaceutical Joint Stock Company No3 reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported revenue was VND 125,520.34 million compared to VND 107,178.83 million a year ago. Net income was VND 40,745.86 million compared to VND 30,692.51 million a year ago. Basic earnings per share from continuing operations was VND 1,800.4 compared to VND 1,356 a year ago.
For the full year, revenue was VND 485,073.79 million compared to VND 381,076.93 million a year ago. Net income was VND 108,824.21 million compared to VND 92,927.04 million a year ago. Basic earnings per share from continuing operations was VND 4,808.4 compared to VND 4,106 a year ago.